37: Optimizing revenue from mature products

36: What’s happening with eCTD 4.0: New and future developments

35: Challenges and best practices for managing local pharmacovigilance activities

34: Environmental Risk Assessment and its growing importance in the German Pharma Strategy

33: Finding the best approach to manage sterility assurance

32: Commercialization Readiness

31: Key Steps for Site Inspection Readiness

30: CSS Overview

29: Exploring the interactions between validation and technology transfer

28: Early access programs: What they are and how to plan for them

27: Assessing gaps and achieving compliance with Annex 1

26: Navigating the Process of Technology Transfer

25: Scaling Patient Safety through Innovation

24: Why Early Phase Modeling is Key to Reimbursement and Patient Access

23: The Unique and Complex World of Combination Products

22: Avoiding Pitfalls with your Product Development Strategy

21: Navigating a complex global regulatory environment to bring medicinal products to market

20: Safety Reporting Requirements for Marketing in the EU

19: The important role of AI in TMF oversight

18: Tackling performance requirements in the more prescriptive world of IVDR